![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2022
Paller, Amy S.; Siegfried, Elaine C.; Cork, Michael J.; Wollenberg, Andreas; Arkwright, Peter D.; Gonzalez, Mercedes E.; Lockshin, Benjamin; Chen, Zhen; Bansal, Ashish; Levit, Noah A. und Prescilla, Randy
(2022):
Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis.
In: Pediatric Drugs, Bd. 25, Nr. 1: S. 67-77
Wollenberg, Andreas; Marcoux, Danielle; Silverberg, Jonathan I.; Aoki, Valeria; Baselga, Eulalia; Zhang, Haixin; Levit, Noah A.; Taieb, Alain und Rossi, Ana B.
(2022):
Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis.
In: Acta Dermato-Venereologica, Bd. 102, adv00726
2021
Paller, Amy S.; Wollenberg, Andreas; Siegfried, Elaine; Thaci, Diamant; Cork, Michael J.; Arkwright, Peter D.; Gooderham, Melinda; Sun, Xian; O'Malley, John T.; Khokhar, Faisal A.; Vakil, Jignesh; Bansal, Ashish; Rosner, Karli; Shumel, Brad und Levit, Noah A.
(2021):
Laboratory Safety of Dupilumab in Patients Aged 6-11 Years with Severe Atopic Dermatitis: Results from a Phase III Clinical Trial.
In: Pediatric Drugs, Bd. 23, Nr. 5: S. 515-527